Financials
- Market Capitalization 11.64 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-37.39
売上高対価格比率
16.85
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 809 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.35 USD | -0.47% | -9.23% | -0.71% | +54.49% | 12.25 B USD | ||
| 817 | HALO Halozyme Therapeutics, Inc. - Common Stock | 106.49 USD | +1.08% | -2.64% | +28.92% | +59.42% | 12.09 B USD | ||
| 850 | TECH Bio-Techne Corp - Common Stock | 72.31 USD | -0.06% | -0.07% | +0.24% | +33.49% | 11.34 B USD | ||
| 869 | SMMT Summit Therapeutics Inc. - Common Stock | 13.62 USD | -0.80% | +2.64% | +5.17% | -31.42% | 10.87 B USD |